Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer

INTRODUCTION: Pembrolizumab cause immune‐related adverse events. We herein report a case of advanced bladder cancer, who treated with pembrolizumab and exhibited intriguing clinical course. CASE PRESENTATION: A 63‐year‐old man with bladder carcinoma was treated by radical cystectomy, however, the bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Todo, Maki, Kaneko, Gou, Shirotake, Suguru, Shimada, Yuki, Nakano, Shintaro, Okabe, Takashi, Ishikawa, Shiho, Oyama, Masafumi, Nishimoto, Koshiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292166/
https://www.ncbi.nlm.nih.gov/pubmed/32743459
http://dx.doi.org/10.1002/iju5.12128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292166/
https://www.ncbi.nlm.nih.gov/pubmed/32743459
http://dx.doi.org/10.1002/iju5.12128

Ejemplares similares